US 11,925,709 B2
Tablet formulation for CGRP active compounds
Log In
Please sign up or log in to access the advanced features of
Ex Parte Enterprise.
or Log in

General

US 11,925,709 B2
Tablet formulation for CGRP active compounds
Tech Center:
1629 Biotechnology and Organic Chemistry
Examiner:
Leslie A. Royds Draper
Art Unit:
1629 Organic Chemistry
Agent:
Foley Hoag LLP
Inventors:
Mary Ann Johnson; Leonardo Resende Allain; W. Mark Eickhoff; Craig B. Ikeda; Chad D. Brown; Francis J. Flanagan, Jr.; Rebecca Nofsinger; Melanie Marota; Lisa Lupton; Paresh B. Patel; Hanmi Xi; Wei Xu
Assignee:
Merck Sharp & Dohme Corp.
Priority:
--
Filed:
12/03/20
Granted:
03/12/24
Expiration:
02/05/34
Cooperative Patent Classification (CPC)
A61A61P25/06A61K31/4545A61P

Analytics

Cases

Patent Assignments

Citations